Pharmaceutical Industry pills

Patents, The Hatch-Waxman Act, and Pharmaceutical Companies

The Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, was enacted to balance incentives for both pharmaceutical innovation and drug affordability by allowing...


Court of Appeals for the Federal Circuit Seal

Motion to Amend in an IPR Defeated in the CAFC

In the recent case Shinn Fu vs. Tire Hanger, No. 16-2250 (Fed. Cir. 2017), decided on July 3, 2017, the United States Court of Appeals for the Federal Circuit (“CAFC”) vacated a Patent Trial and...